News

Covid-19 and MS-patient treatment

In view of the most recent changes in advice/restrictions to the general population, the board of the Belgian Study Group of MS (BSGMS) strengthens its advice to neurologists regarding the treatment of MS patients. Therefore, following recommendations apply: 1. The preventive measures provided to the general population (https://www.info-coronavirus.be/nl/ or https://www.info-coronavirus.be/fr/) do apply even more to…

Détails

Covid-19 : general guidelines

In line with its mission to support the treatment of MS, the Belgian Study Group for MS (BSGMS) would like to provide you with a response to some frequently asked questions regarding the current coronavirus issue. Most importantly we adhere to the guidelines of our health authorities: https://www.info-coronavirus.be/nl/ or https://www.info-coronavirus.be/fr/, which are updated when necessary.…

Détails

Mission

The organisation’s non-profit purpose is to encourage and develop in Belgium, in cooperation with the Belgian Charcot Foundation – the foundation of public interest which it created – the study and treatment of multiple sclerosis, by means of the various scientific-research disciplines available, in particular clinical research, biology, biochemistry, electrophysiology, immunology, virology, genetics, epidemiology and anatomopathology.

The Board

Chairman: Prof Bénédicte Dubois

Vice-president: Prof Guy Laureys

Secretary: Dr Dominique Dive

Members: Dr Emmanuel Bartholomé, Dr Melissa Cambron, Dr Brigitte Capron, Dr Bernard Dachy, Dr Danny Decoo, Prof Soraya El Sankari, Dr Frederic London, Dr Gaetano Perrotta, Prof. Veronica Popescu, Prof Vincent van Pesch, Prof Bart Van Wijmeersch, Dr Barbara Willekens

Executive officer : Mrs Isabelle Bloem-Gonsette

BELTRIMS

BELTRIMS (Belgian Treatment in Multiple Sclerosis) :

Le but de ce registre est de collecter des données, en situation réelle, sur la tolérance et l’efficacité des nouveaux médicaments, de détecter à court et long terme des effets secondaires inconnus ou sous-évalués et d’étudier les effets éventuels des médicaments concernés en cas de grossesse.

Het doel van het register is het verzamelen van real life data over de tolerantie en de werkzaamheid van de nieuwe behandelingen, om zo op korte en lange termijn nog niet ontdekte bijwerkingen in het licht te stellen en de eventuele effecten op zwangerschap te bestuderen.

Agenda

05/05/2020 : cancelled

BSGMS General Assembly : Taking into account the COVID-19 pandemics, the Board of the BSGMS decided to postpone the General Assembly. Information will follow asap.

 

 

Contact

(*) Required fields